Voltar
Artigo Revisado por pares
BIBTEX RIS

Phase I and pharmacokinetic trial of AP5346, a DACH–platinum–polymer conjugate, administered weekly for three out of every 4 weeks to advanced solid tumor patients

2007; Springer Science+Business Media; Volume: 60; Issue: 4 Linguagem: Inglês

10.1007/s00280-006-0397-0

ISSN

1432-0843

Autores

Mario Campone, Jeany M. Rademaker-Lakhai, Jaafar Bennouna, Stephen B. Howell, David P. Nowotnik, Jos H. Beijnen, Jan H.M. Schellens,

Tópico(s)

Cancer therapeutics and mechanisms

Referência(s)